Passa al contenuto
Merck

Mitochondrial replacement in an iPSC model of Leber's hereditary optic neuropathy.

Aging (2017-04-30)
Raymond C B Wong, Shiang Y Lim, Sandy S C Hung, Stacey Jackson, Shahnaz Khan, Nicole J Van Bergen, Elisabeth De Smit, Helena H Liang, Lisa S Kearns, Linda Clarke, David A Mackey, Alex W Hewitt, Ian A Trounce, Alice Pébay
ABSTRACT

Cybrid technology was used to replace Leber hereditary optic neuropathy (LHON) causing mitochondrial DNA (mtDNA) mutations from patient-specific fibroblasts with wildtype mtDNA, and mutation-free induced pluripotent stem cells (iPSCs) were generated subsequently. Retinal ganglion cell (RGC) differentiation demonstrates increased cell death in LHON-RGCs and can be rescued in cybrid corrected RGCs.

MATERIALI
N° Catalogo
Marchio
Descrizione del prodotto

Sigma-Aldrich
Anticorpo anti-TRA-1-60, clone TRA-1-60, clone TRA-1-60, Chemicon®, from mouse
Sigma-Aldrich
MISSION® esiRNA, targeting human TP53
Sigma-Aldrich
Anti-AFP Mouse mAb (1G7), liquid, clone 1G7, Calbiochem®